Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,531 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of ormutivimab, a novel recombinant human anti-rabies monoclonal antibody, in post-exposure prophylaxis animal models.
Zhai LL, Wang H, Zhao W, Zhang SF, Miao FM, Cao Y, Chen C, Li YF, Gao J, Lv RY, Zhang SX, Cao JB, Zhang XF, Yang MM, Zhang B, Zhao J, Wei JS, Gao J. Zhai LL, et al. Among authors: wei js. Travel Med Infect Dis. 2022 Mar-Apr;46:102267. doi: 10.1016/j.tmaid.2022.102267. Epub 2022 Jan 25. Travel Med Infect Dis. 2022. PMID: 35091118
Rabies Virus Neutralizing Activity, Safety, and Immunogenicity of Recombinant Human Rabies Antibody Compared with Human Rabies Immunoglobulin in Healthy Adults.
Zhang JN, Meng YJ, Bai YH, Li YF, Yang LQ, Shi NM, Han HX, Gao J, Zhu LJ, Li SP, Zhang J, Zhao QH, Wang XQ, Wei JS, Ren LM, Cao CH, Chen C, Zhao W, Li L. Zhang JN, et al. Among authors: wei js. Biomed Environ Sci. 2022 Sep 20;35(9):782-791. doi: 10.3967/bes2022.103. Biomed Environ Sci. 2022. PMID: 36189993 Free article. Clinical Trial.
Comparing recombinant human rabies monoclonal antibody (ormutivimab) with human rabies immunoglobulin (HRIG) for postexposure prophylaxis: A phase III, randomized, double-blind, non-inferiority trial.
Liu X, Li Y, Li J, Zhou J, Guo J, Pu Y, Jiang Y, Zhou Y, Jiang Z, Shu Q, Wang C, Wang J, Zhao Y, Zhao W, Wang H, Wei J, Yu H, Gao J, Li X. Liu X, et al. Among authors: wei j. Int J Infect Dis. 2023 Sep;134:53-62. doi: 10.1016/j.ijid.2023.05.017. Epub 2023 May 19. Int J Infect Dis. 2023. PMID: 37211270 Free article. Clinical Trial.
18,531 results
You have reached the last available page of results. Please see the User Guide for more information.